Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-25T23:56:52.242Z Has data issue: false hasContentIssue false
  • English
  • Français

Nosocomial Infections in HIV-Infected Patients Preliminary Results from a Multicenter Surveillance System (1989-1995)

Published online by Cambridge University Press:  02 January 2015

Leonardo Stroud ,
Pamela Srivastava ,
David Culver ,
Alan Bisno ,
David Rimland ,
Michael Simberkoff ,
Harvey Elder ,
Joshua Fierer ,
William Martone  and
Robert Gaynes
Leonardo Stroud*
Affiliation:
Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
Pamela Srivastava
Affiliation:
Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
David Culver
Affiliation:
Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
Alan Bisno
Affiliation:
Division of Infectious Diseases, Department of Medicine, Miami Veterans' Affairs Medical Center, Miami, Florida
David Rimland
Affiliation:
Division of Infectious Diseases, Department of Medicine, Atlanta Veterans' Affairs Medical Center and Georgia Research Center on AIDS and HIV Infection, Atlanta, Georgia
Michael Simberkoff
Affiliation:
Division of Infectious Diseases, Department of Medicine, New York Veterans' Affairs Medical Center, New York, New York
Harvey Elder
Affiliation:
Infectious Disease Section, Medicine Service, Pettis Memorial Veterans' Affairs Medical Center, Loma Linda, California
Joshua Fierer
Affiliation:
Division of Infectious Diseases, Department of Medicine, San Diego Veterans' Affairs Medical Center, San Diego, California
William Martone
Affiliation:
Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
Robert Gaynes
Affiliation:
Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
*
Mailstop E-55, Hospital Infections Program, Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To describe the characteristics of and trends in nosocomial infection among human immunodeficiency virus (HIV)-infected patients.

Design:

Multicenter prospective cohort study.

Setting/Patients:

HIV-infected patients were enrolled at time of first inpatient admission at five Veterans' Administration Medical Centers (VAMCs).

Results:

As of March 1995, 2,541 patients with 6,625 inpatient admissions had been monitored in the five VAMCs. A total of 530 nosocomial infections were detected using standard Centers for Disease Control and Prevention definitions. Overall distribution by infection site was 31% for primary bloodstream infections (BSIs), 28% for urinary tract infections, 15% for pneumonia, and 26% for all other sites. Of BSIs, 63% were central line-associated bloodstream infections (CLABs). The rate of CLABs per 1,000 central line days was 6.5 (range, 2.3-8.3) for all patients from participating hospitals, similar to the median CLAB rate of 6.0 for patients in medical intensive-care units (ICUs) of National Nosocomial Infections Surveillance (NNIS) System hospitals from January 1990 through September 1994. For ICU-specific CLABs, the rate from hospitals reporting at least one ICU CLAB was 12.7 (range, 12.1-13.1), comparable to the 90th percentile of NNIS hospital medical ICUs (13.1). Staphylococcus aureus, associated with 35% of BSIs, was the most common nosocomial BSI pathogen. Our data demonstrated the following: 13 (10%) of 134 patients with CD4 counts ≥200 cells/mm3 had a CLAB, compared with 61 (6%) of 1,011 patients with CD4 counts <200 cells/mm3, P=.08; the per-day risk of CLABs did not change with increased duration of catheterization (P=.4); and the per-day risk of a temporary (ie, short-term) CLAB was greater than that of a permanent CLAB (P<.001).

Conclusions:

The data suggest that HIV-infected patients were at higher risk of acquiring a BSI than were patients in the NNIS population; patients with CD4 counts ≥200 cell/mm3 and temporary central lines were at increased risk for BSI, perhaps reflecting widespread prophylaxis with trimethoprim-sulfamethoxazole among patients with CD4 counts <200 cells/mm3; and, in contrast to most studies, S aureus, not coagulase-negative Staphylococcus, was the most common BSI pathogen.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 18 , Issue 7 , July 1997 , pp. 479 - 485
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1997

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report. 1994;6(no. 2):1–39.Google Scholar
2. US Public Health Service, Centers for Disease Control and Prevention, National Center for Health Statistics. National Hospital Discharge Survey: Annual Summary, 1991: Series 13, No. 114, 07 1993.Google Scholar
3. Banerjee, S, Emori, TG, Culver, DH, et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. Am J Med 1991;91(suppl 3B):86–89.Google Scholar
4. Centers for Disease Control. Public health focus: surveillance, prevention, and control of nosocomial infections. MMWR 1992;41:783–787.Google Scholar
5. Haley, RW, Culver, DH, White, JW, Morgan, WM, Emori, TG. The nationwide nosocomial infection rate: a new need for vital statistics. Am J Epidemiol 1985;121:159–167.Google Scholar
6. Haley, RW, Culver, DH, White, JW, et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 1985;121:182–205.Google Scholar
7. Martone, WJ, Jarvis, WR, Culver, DH, Haley, RW. Incidence and nature of endemic and epidemic nosocomial infections. In: Bennett, JV, Brachman, PS, eds. Hospital Infections. Boston, MA: Little, Brown, and Co; 1992:577–596.Google Scholar
8. Garner, JS, Jarvis, WR, Emori, TG, Horan, TC, Hughes, JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128–140.CrossRefGoogle ScholarPubMed
9. Centers for Disease Control. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. MMWR 1986;35:334–339.Google Scholar
10. Emori, TG, Culver, DH, Horan, TC, et al. National Nosocomial Infections Surveillance (NNIS) System: description of methodology and surveillance components. Am J Infect Control 1991;19:19–36.Google Scholar
11. Jarvis, WR, Edwards, JR, Culver, DH, et al. Nosocomial infection rates in adults and pediatric intensive care units in the United States. Am J Med 1991;91(suppl 3B):185–191.Google Scholar
12. Emori, TG, Gaynes, RP. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 1993;6:428–442.Google Scholar
13. Goetz, AM, Squier, C, Wagener, MM, Muder, RR. Nosocomial infections in the human immunodeficiency virus-infected patient: a two-year survey. Am J Infect Control 1994;23:334–339.Google Scholar
14. Richet, H, Hubert, B, Nitemberg, G, Andremont, A, Buu-Hoi, A, Ourbak, P. Prospective multicenter study of vascular-catheter-related complications and risk factors for positive central-catheter cultures in intensive care unit patients. J Clin Microbiol 1990;28:2520–2525.Google Scholar
15. Schaberg, DR, Culver, DH, Gaynes, RP. Major trends in the microbial etiology of nosocomial infection. Am J Med 1991;91(suppl 3B):72S–75S.CrossRefGoogle ScholarPubMed
16. Jacobson, MA, Gellermann, H, Chambers, H. Staphylococcus aureus bacteremia and recurrent staphylococcal infection in patients with acquired immunodeficiency syndrome and AIDS-related complex. Am J Med 1988;85:172–176.Google Scholar
17. Whimbey, E, Gold, JW, Polsky, B, et al. Bacteremia and fungemia in patients with acquired immunodeficiency syndrome. Ann Intern Med 1986;104:511–514.Google Scholar
18. Raviglione, MC, Battan, R, Pablos-Mendez, A, Aceves-Casillas, P, Mullen, MP, Tatanta, A. Infections associated with Hickman catheters in patients with acquired immunodeficiency syndrome. Am J Med 1989;86:780–786.Google Scholar
19. Tuazon, CU, Sheagren, JN. Increased rate of carriage of Staphylococcus aureus among narcotic addicts. J Infect Dis 1974;129:725–727.CrossRefGoogle ScholarPubMed
20. Tuazon, CU, Sheagren, JN. Staphylococcal endocarditis in parenteral drug abusers: source of the organism. Ann Intern Med 1975;82:788–790.Google Scholar
21. Raviglione, MC, Mariuz, P, Pablos-Mendez, A, Battan, R, Ottuso, P, Taranta, A. High Staphylococcus aureus nasal carriage rate in patients with acquired immunodeficiency syndrome or AIDS-related complex. Am J Infect Control 1990;18:64–69.CrossRefGoogle ScholarPubMed
22. Ganesh, R, Castle, D, McGibbon, D, Phillips, I, Bradbeer, C. Staphylococcal carriage and HIV infection. Lancet 1989;2:558. Letter.Google Scholar
23. Goldblum, SE, Reed, WP, Ulrich, JA, Goldman, RS. Staphylococcal carriage and infections in hemodialysis patients. Dial Transplant 1978;7:1140–1148.Google Scholar
24. Valvano, MA, Hartstein, VH, Morthland, ME, et al. Plasmid DNA analysis of Staphylococcus epidermidis isolated from blood and colonization cultures in very low birth weight neonates. Pediatr Infect Dis J 1988;7:116–120.Google Scholar
25. Yu, VL, Goetz, A, Wagener, M, et al. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. N Engl J Med 1986;315:91–96.Google Scholar
26. Bary, M, Cazala, JB, Vittecoq, D, Boucot, I, Berche, P, Bach, JF. Central venous catheters (CVC) in AIDS: risk factors for bacterial infection. Proceedings of the Sixth International Conference on AIDS; 06 1990; San Francisco, CA. Abstract Th.B.528.Google Scholar
27. Weinke, T, Rogler, G, Rohde, I, Pohle, HD. Bacteremia in adult HIV-infected patients. Proceedings of the Sixth International Conference on AIDS; 06 1990; San Francisco, CA. Abstract Th.8.525.Google Scholar
28. Goldblum, SE, Reed, WP. Host defenses and immunologic alterations associated with chronic hemodialysis. Ann Intern Med 1980;93:597–613.Google Scholar
29. Cheesbrough, JS, Finch, RG, Burder, RP. A prospective study of the mechanisms of infection associated with hemodialysis catheters. J Infect Dis 1986;154:79–89.Google Scholar
30. Vanherweghem, JL, Dhaene, M, Goldman, M, et al. Infections associated with subclavian dialysis catheters: the key role of nurse training. Nephron 1986;42:116–119.Google Scholar
31. Hughes, WT, Kuhn, S, Chaudhary, S, et al. Successful chemo-prophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med 1977;297:1419–1426.Google Scholar
32. EORTC International Antimicrobial Therapy Project Group. Trimethoprim-sulfamethoxazole in the prevention of infection in neutropenic patients. J Infect Dis 1984;150:372–379.Google Scholar
33. Gurwith, MJ, Brunton, JL, Lank, BA, Harding, GKM, Ronald, AR. A prospective controlled investigation of prophylactic trimethoprim/sulfamethoxazole in hospitalized granulocy-topenic patients. Am J Med 1979;66:248.CrossRefGoogle ScholarPubMed
34. Gualtieri, RJ, Donowitz, GR, Kaiser, DL, Hess, CE, Sande, MA. Double-blind randomized study of prophylactic trimethoprim/sulfamethoxazole in granulocytopenic patients with hematologic malignancies. Am J Med 1983;74:984.Google Scholar
35. Riben, PD, Louie, TJ, Lank, BA, et al. Reduction in mortality from gram-negative sepsis in neutropenic patients receiving trimethoprim/sulfamethoxazole therapy. Cancer 1983;51:1587.Google Scholar
36. Kovatch, AL, Wald, ER, Albo, VC, et al. Oral trimethoprim/sulfamethoxazole for prevention of bacterial infection during induction phase of cancer chemotherapy in children. Pediatrics 1985;76:754.Google Scholar
37. Abraham, JL, Mullen, JL. A prospective study of prolonged central venous access in leukemia. JAMA 1982;248:2868–2873.CrossRefGoogle Scholar
38. Eyer, S, Brummit, C, Crossley, K, Siegel, R, Cerra, F. Catheter-related sepsis: randomized study of three methods of long-term catheter maintenance. Crit Care Med 1990;18:1073–1079.Google Scholar
39. Stenzel, JP, Green, TP, Fuhrman, BP, et al. Percutaneous central venous catheterization in a pediatric intensive care unit: a survival analysis of complication. Crit Care Med 1989;17:984–988.CrossRefGoogle Scholar
40. Cobb, DK, High, KP, Sawyer, RG, et al. A controlled trial of scheduled replacement of central venous and pulmonary-artery catheters. N Engl J Med 1992;327:1062–1068.Google Scholar